Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue

Patent metadata

Field	Value
Publication number	US-11377486-B2
Application number	US-201916536500-A
Country	US
Kind code	B2
Filing date	Aug 9, 2019
Priority date	Nov 5, 2010
Publication date	Jul 5, 2022
Grant date	Jul 5, 2022

Abstract

There is provided a motif-specific, context-independent antibody that specifically binds a recurring, modified motif consisting of (i) at least one sumoylated lysine residue, and (ii) one or more degenerate amino acids bound by a peptide bond to said sumoylated lysine residue, said antibody specifically binding said motif in a plurality of non-homologous peptides or proteins within an organism in which it recurs. Also provided is a motif-specific, context-independent antibody that specifically binds a recurring, modified motif consisting of (i) a C-terminal aspartic acid residue, and (ii) one or more degenerate amino acids bound by a peptide bond to said C-terminal aspartic acid residue, said antibody specifically binding said motif in a plurality of non-homologous peptides or proteins within an organism in which it recurs.

First claim

What is claimed is:

1. A method of producing a purified motif-specific, context-independent antibody that specifically binds a motif comprising (i) a sequence of ψ-K-X-D, wherein ψ is a hydrophobic amino acid residue, K is a sumoylated lysine residue, X is any amino acid residue, and D is an aspartic acid residue, and (ii) one or more degenerate amino acids bound by a peptide bond to the sumoylated lysine residue, wherein the method comprises (a) constructing a degenerate peptide library comprising (i) the motif and (ii) a plurality of degenerate amino acids flanking said motif; (b) immunizing a host with said peptide library to raise a context-independent antibody specific for all or part of said motif; and (c) isolating antisera from said host, and purifying the motif-specific, context-independent antibody of step (b) from said antisera.

2. The method of claim 1 , wherein the sumoylated lysine residue is a lysine residue attached via an epsilon amine of said lysine residue to a C-terminal G of the fragment of a SUMO protein, wherein said fragment comprises the sequence TGG.

3. The method of claim 1 , wherein the sumoylated lysine residue is a lysine residue attached via an epsilon amine of said lysine residue to a C-terminal G of the fragment of a SUMO protein, wherein said fragment comprises the sequence QTGG (SEQ ID NO:147).

4. The method of claim 1 , wherein the sumoylated lysine residue is a lysine residue attached via an epsilon amine of said lysine residue to a C-terminal G of the fragment of a SUMO protein, wherein said fragment comprises a sequence selected from the group consisting of VYQEQTGG (SEQ ID NO:148), YQEQTGG (SEQ ID NO:149), QEQTGG (SEQ ID NO:150), EQTGG (SEQ ID NO:151), DVFQQQTGG (SEQ ID NO:152), VFQQQTGG (SEQ ID NO:153), FQQQTGG (SEQ ID NO:154), QQQTGG (SEQ ID NO:155), and QQTGG (SEQ ID NO:156).

5. The method of claim 1 , wherein the antibody is a rabbit antibody.

6. The method of claim 1 , wherein the antibody is a monoclonal antibody.

Assignees

• Cell Signaling Technology Inc

Inventors

• Comb Michael
• Guo Ailan
• Rush Ii John Edward
• Cai Jun-Ming
• Li Jing
• Zhou Jing

Classifications

• C07K16/44 Primary

  against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title

• C07K2317/20

  characterized by taxonomic origin · CPC title

• C07K2317/34

  Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues · CPC title

• C07K16/18 Primary

  against material from animals or humans · CPC title

• C07K2317/14

  Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title